Comparative Analysis of the Human Proteome Profile in Visceral Adipose and Liver Tissue in Individuals with Obesity with and Without MASLD and MASH

Background/Objectives: Visceral adipose tissue (VAT) may play a direct role in the development of metabolic dysfunction-associated steatotic liver disease (MASLD) and its progression to metabolic dysfunction-associated steatohepatitis (MASH). In this study, we employed untargeted proteomics analyses...

Full description

Saved in:
Bibliographic Details
Main Authors: Julie S. Pedersen, Lili Niu, Nicolai J. Wewer Albrechtsen, Viggo B. Kristiansen, Inge Marie Poulsen, Reza R. Serizawa, Torben Hansen, Lise Lotte Gluud, Sten Madsbad, Flemming Bendtsen
Format: Article
Language:English
Published: MDPI AG 2025-04-01
Series:Livers
Subjects:
Online Access:https://www.mdpi.com/2673-4389/5/2/16
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850167407510814720
author Julie S. Pedersen
Lili Niu
Nicolai J. Wewer Albrechtsen
Viggo B. Kristiansen
Inge Marie Poulsen
Reza R. Serizawa
Torben Hansen
Lise Lotte Gluud
Sten Madsbad
Flemming Bendtsen
author_facet Julie S. Pedersen
Lili Niu
Nicolai J. Wewer Albrechtsen
Viggo B. Kristiansen
Inge Marie Poulsen
Reza R. Serizawa
Torben Hansen
Lise Lotte Gluud
Sten Madsbad
Flemming Bendtsen
author_sort Julie S. Pedersen
collection DOAJ
description Background/Objectives: Visceral adipose tissue (VAT) may play a direct role in the development of metabolic dysfunction-associated steatotic liver disease (MASLD) and its progression to metabolic dysfunction-associated steatohepatitis (MASH). In this study, we employed untargeted proteomics analyses on paired biopsies from VAT and liver tissues of patients with obesity, MASLD, and MASH. Our objective was to investigate tissue-specific protein expression patterns in search of a potential proteomic signature associated with MASH in both VAT and liver tissue. Methods: VAT and liver tissue were collected from 70 subjects with severe obesity (SWOs) and nine control study subjects without obesity (CON). SWOs were stratified on the basis of liver histology into LS− (no liver steatosis), LS+ (liver steatosis), and MASH. Peptides were extracted from frozen tissue and were analyzed by liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). Raw files were analyzed with Spectronaut, proteins were searched against the human FASTA Uniprot database, and the significantly expressed proteins in the two tissues were analyzed. The <i>p</i>-values were false discovery rate (FDR) corrected. Results: A total of 59 VAT and 42 liver proteins were significantly differentially expressed between the four groups: LS−, LS+, MASH, and CON. The majority were upregulated, and many were related to lipid metabolism. In VAT, only one protein, the mitochondrial sulfide:quinone oxidoreductase (SQOR), was significantly downregulated in the MASH group only. In liver tissue from patients with MASH, six proteins were significantly altered compared with the three other groups. Correlation analyses between the top 10 positive VAT and liver proteins were dominated by inflammatory and detoxification proteins. Conclusions: The presence of MASH was not reflected in the VAT proteome, and both the VAT and the liver proteome were generally affected more by the presence of obesity than by MASLD severity. Several immunomodulating proteins correlated significantly between VAT and liver tissue and could reflect common pathophysiological characteristics.
format Article
id doaj-art-a72c64a27cd342d0917fb1ae5921e76a
institution OA Journals
issn 2673-4389
language English
publishDate 2025-04-01
publisher MDPI AG
record_format Article
series Livers
spelling doaj-art-a72c64a27cd342d0917fb1ae5921e76a2025-08-20T02:21:13ZengMDPI AGLivers2673-43892025-04-01521610.3390/livers5020016Comparative Analysis of the Human Proteome Profile in Visceral Adipose and Liver Tissue in Individuals with Obesity with and Without MASLD and MASHJulie S. Pedersen0Lili Niu1Nicolai J. Wewer Albrechtsen2Viggo B. Kristiansen3Inge Marie Poulsen4Reza R. Serizawa5Torben Hansen6Lise Lotte Gluud7Sten Madsbad8Flemming Bendtsen9Gastrounit, Medical Division, Copenhagen University Hospital Hvidovre, Kettegaard Allé 30, 2650 Hvidovre, DenmarkNNF Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen, DenmarkNNF Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen, DenmarkGastrounit, Surgical Division, Copenhagen University Hospital Hvidovre, Kettegaard Allé 30, 2650 Hvidovre, DenmarkGastrounit, Surgical Division, Copenhagen University Hospital Hvidovre, Kettegaard Allé 30, 2650 Hvidovre, DenmarkDepartment of Pathology, Copenhagen University Hospital Hvidovre, Kettegaard Allé 30, 2650 Hvidovre, DenmarkNNF Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen, DenmarkGastrounit, Medical Division, Copenhagen University Hospital Hvidovre, Kettegaard Allé 30, 2650 Hvidovre, DenmarkDepartment of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen, DenmarkGastrounit, Medical Division, Copenhagen University Hospital Hvidovre, Kettegaard Allé 30, 2650 Hvidovre, DenmarkBackground/Objectives: Visceral adipose tissue (VAT) may play a direct role in the development of metabolic dysfunction-associated steatotic liver disease (MASLD) and its progression to metabolic dysfunction-associated steatohepatitis (MASH). In this study, we employed untargeted proteomics analyses on paired biopsies from VAT and liver tissues of patients with obesity, MASLD, and MASH. Our objective was to investigate tissue-specific protein expression patterns in search of a potential proteomic signature associated with MASH in both VAT and liver tissue. Methods: VAT and liver tissue were collected from 70 subjects with severe obesity (SWOs) and nine control study subjects without obesity (CON). SWOs were stratified on the basis of liver histology into LS− (no liver steatosis), LS+ (liver steatosis), and MASH. Peptides were extracted from frozen tissue and were analyzed by liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). Raw files were analyzed with Spectronaut, proteins were searched against the human FASTA Uniprot database, and the significantly expressed proteins in the two tissues were analyzed. The <i>p</i>-values were false discovery rate (FDR) corrected. Results: A total of 59 VAT and 42 liver proteins were significantly differentially expressed between the four groups: LS−, LS+, MASH, and CON. The majority were upregulated, and many were related to lipid metabolism. In VAT, only one protein, the mitochondrial sulfide:quinone oxidoreductase (SQOR), was significantly downregulated in the MASH group only. In liver tissue from patients with MASH, six proteins were significantly altered compared with the three other groups. Correlation analyses between the top 10 positive VAT and liver proteins were dominated by inflammatory and detoxification proteins. Conclusions: The presence of MASH was not reflected in the VAT proteome, and both the VAT and the liver proteome were generally affected more by the presence of obesity than by MASLD severity. Several immunomodulating proteins correlated significantly between VAT and liver tissue and could reflect common pathophysiological characteristics.https://www.mdpi.com/2673-4389/5/2/16MASLDMASHuntargeted proteomicsliver tissuevisceral adipose tissueobesity
spellingShingle Julie S. Pedersen
Lili Niu
Nicolai J. Wewer Albrechtsen
Viggo B. Kristiansen
Inge Marie Poulsen
Reza R. Serizawa
Torben Hansen
Lise Lotte Gluud
Sten Madsbad
Flemming Bendtsen
Comparative Analysis of the Human Proteome Profile in Visceral Adipose and Liver Tissue in Individuals with Obesity with and Without MASLD and MASH
Livers
MASLD
MASH
untargeted proteomics
liver tissue
visceral adipose tissue
obesity
title Comparative Analysis of the Human Proteome Profile in Visceral Adipose and Liver Tissue in Individuals with Obesity with and Without MASLD and MASH
title_full Comparative Analysis of the Human Proteome Profile in Visceral Adipose and Liver Tissue in Individuals with Obesity with and Without MASLD and MASH
title_fullStr Comparative Analysis of the Human Proteome Profile in Visceral Adipose and Liver Tissue in Individuals with Obesity with and Without MASLD and MASH
title_full_unstemmed Comparative Analysis of the Human Proteome Profile in Visceral Adipose and Liver Tissue in Individuals with Obesity with and Without MASLD and MASH
title_short Comparative Analysis of the Human Proteome Profile in Visceral Adipose and Liver Tissue in Individuals with Obesity with and Without MASLD and MASH
title_sort comparative analysis of the human proteome profile in visceral adipose and liver tissue in individuals with obesity with and without masld and mash
topic MASLD
MASH
untargeted proteomics
liver tissue
visceral adipose tissue
obesity
url https://www.mdpi.com/2673-4389/5/2/16
work_keys_str_mv AT juliespedersen comparativeanalysisofthehumanproteomeprofileinvisceraladiposeandlivertissueinindividualswithobesitywithandwithoutmasldandmash
AT liliniu comparativeanalysisofthehumanproteomeprofileinvisceraladiposeandlivertissueinindividualswithobesitywithandwithoutmasldandmash
AT nicolaijweweralbrechtsen comparativeanalysisofthehumanproteomeprofileinvisceraladiposeandlivertissueinindividualswithobesitywithandwithoutmasldandmash
AT viggobkristiansen comparativeanalysisofthehumanproteomeprofileinvisceraladiposeandlivertissueinindividualswithobesitywithandwithoutmasldandmash
AT ingemariepoulsen comparativeanalysisofthehumanproteomeprofileinvisceraladiposeandlivertissueinindividualswithobesitywithandwithoutmasldandmash
AT rezarserizawa comparativeanalysisofthehumanproteomeprofileinvisceraladiposeandlivertissueinindividualswithobesitywithandwithoutmasldandmash
AT torbenhansen comparativeanalysisofthehumanproteomeprofileinvisceraladiposeandlivertissueinindividualswithobesitywithandwithoutmasldandmash
AT liselottegluud comparativeanalysisofthehumanproteomeprofileinvisceraladiposeandlivertissueinindividualswithobesitywithandwithoutmasldandmash
AT stenmadsbad comparativeanalysisofthehumanproteomeprofileinvisceraladiposeandlivertissueinindividualswithobesitywithandwithoutmasldandmash
AT flemmingbendtsen comparativeanalysisofthehumanproteomeprofileinvisceraladiposeandlivertissueinindividualswithobesitywithandwithoutmasldandmash